published study has suggested that the microcirculation of the inner ear may be impaired in patients with hyperlipidemia. 3 In this study, we aimed at assessing the potential associations between hyperlipidemia and NIHL.
Material and Methods
This cross-sectional study was conducted in our ear, nose and throat (ENT) clinic between December 2014 and December 2015. The workers to be included in the study were selected among those who had been exposed to at least 85 dB of occupational noise for at least 10 years. The workers who were included in the study were mainly from metallurgy, engine manufacturing and foundry industries. All participants were examined by an experienced physician. The exclusion criteria were previous ear surgery, sudden hearing loss, ototoxic drug use, history of ear trauma, any chronic disease, regular drug use, history of familial hypercholesterolemia, and age > 45 years. All participants provided informed consent forms and were informed about the study and the study tests. Audiometric testing was performed by an experienced audiometrist using a Maico MA 53 Audiometer device (Maico Diagnostics, Berlin, Germany). Seven test frequencies were recorded during the audiometric tests: 500 Hz, 1,000 Hz, 2,000 Hz, 3,000 Hz, 4,000 Hz, 6,000 Hz and 8,000 Hz. We defined occupational hearing loss as a notch observed at 3 kHz, 4 kHz and 6 kHz with recovery at 8 kHz. 4 The study population was divided into a control group ( 25 dB) and an NIHL group (> 25 dB), based on the level of the hearing loss. The study population was further divided into hypercholesterolemia (> 200), normal cholesterol level (< 200), hypertriglyceridemia and normal triglyceride level, based on the US National Institute of Health Adult TreatmentPanel III (ATP III) guidelines.
5
Blood samples for biochemistry analyses were collected at 08.00 AM following 12 hours of fasting. Blood total cholesterol, triglycerides, low-density lipoprotein (LDL) and highdensity lipoprotein (HDL) levels were measured. Total cholesterol, total triglycerides, and LDL cholesterol levels were measured by an enzymatic method, while the level of the HDL cholesterol was measured by the immunoinhibition method, using an Olympus AU 2700 analyzer (Olympus life and material science GmbH, Dublin, Ireland). The level of LDL cholesterol was calculated by the Friedewald's formula, as follows:
The Statistical Package for the Social Sciences (SPSS) 22.0 software (IBM SPSS Statistics, Armonk, NY, USA) was used for the statistical analyses. The correlation analysis was used to detect correlations among the data. Descriptive data were presented as means AE standard deviation (SD), and the Student's t-test was used for continuous data. The logistic regression analysis was used to estimate the odds ratios (at a 95% confidence level [95%CI]). Any p-value lower than 0.05 was considered statistically significant.
This study was conducted in line with the 2013 version of the Declaration of Helsinki. The study was approved by the Institutional Review Board (decision No. 2014-89513307/ 1008/398).
Results
A total of 608 workers were screened, and 152 workers who did not met inclusion criteria were excluded from the study. The remaining 456 workers aged 30 to 45 years were included in the study. Based on the hearing level, 252 subjects were included in the control group, and 204 subjects were included in the NIHL group. Descriptive data by group are shown in ►Table 1. The groups were matched by age and occupational exposure (p > 0.05).
No association was found between the blood cholesterol level and the NIHL (p > 0.05). The analyses of the sub-groups did not reveal any significant difference. Based on the logistic regression analyses, the odds ratio for hypercholesterolemia was found to be 0.948 (95%CI: 0.786-1.142; p > 0.05), and for hypertriglyceridemia, it was 0.928 (95%CI: 0.886-1.162; p > 0.05). In addition, no significant difference was found between the blood HDL level and the level of exposure to noise.
Discussion
Factors underlying sensorineural hearing loss have been previously investigated in many studies that followed several study models. Viral infections, tumors, ototoxic drugs, ear surgery, chronic middle ear infections, trauma and medical conditions were found to be associated with this pathological condition. Hypercholesterolemia is an important condition that may lead to sensorineural hearing loss, and may contribute to sensorineural hearing loss in a variety of ways.
6
Noise-induced hearing loss may only result from prolonged exposure to noise. The pathogenesis and predisposing factors for this occupational condition remain unknown. Studies using animal models and histopathological analyses in humans have aimed at determining the underlying mechanism of hearing loss. These studies indicated cellular damage and functional loss in the organ of Corti, in a similar way to ototoxicity studies. Furthermore, there are studies indicating elevated reactive oxygen species (ROS) levels in the inner ear, following the exposure to noise. These oxidative products affect neurosensory epithelium (NSE) cells, such as inner hair cells (IHCs), outer hair cells (OHCs) and supporting cells.
7-9
Another molecular mechanism under investigation is the genetic predisposition. Previous studies demonstrated that acoustic trauma might induce the activation of extracellular signal-regulated kinases (ERKs) and phosphorylation in the IHCs. Although this mechanism was demonstrated at the level of the neurosensory epithelial tissue, it is not clear whether these genes have protective or damaging effects, since there are controversial publications for both situations.
7-11
All of these studies were based on the exposure to shortterm, high-frequency noise. 12, 13 Controlled human studies with histopathological analyses cannot be conducted due to ethical issues. Another factor that may lead to hearing loss is the insufficient microcirculation in the inner ear. 13 This problem may be associated with atherosclerosis and hypercholesterolemia. 14 Microcirculatory disturbance in the inner ear may result in sudden hearing loss, since the inner ear has no collateral microcirculation. However, this situation may not be involved in the development of NIHL. Whether or not there is an association between vascular insufficiency and NIHL is a question that remains unanswered. Only the circulatory measurements and histopathological examination of the blood vessels may provide an answer to this question. Cochlear microcirculation has been studied in in vivo animal studies integrated with mathematic models; however, we do not yet have any effective diagnostic screening tools. 15, 16 In this study, we investigated the potential associations between the blood cholesterol levels of the workers and their hearing level. As stated in the Methodology section, comparisons were performed between cholesterol groups and the total duration of the exposure to noise. According to our results, no significant association was found between cholesterol levels and NIHL. Although the results of previous studies are in line with those of our study, the total duration of the exposure to noise and the different cholesterol levels were not analyzed in those studies.
17 Unlike our study, certain studies found associations between an increased incidence of NIHL and hypertriglyceridemia as well as hypercholesterolemia. All of those studies had limitations due to the potential bias resulting from the total duration of the exposure to noise and the wide age distribution. In addition, those studies lacked histopathological verification, as did ours.
18
It is a well-known fact that life expectancy has been increasing during the last century, and, therefore, the elimination of daily environmental noise sources as well as the elimination of presbyacusis present challenges. Consequently, postmortem histopathological studies have limited contribution when it comes to shedding light on this issue.
Conclusion
Noise-induced hearing loss is an ongoing occupational problem that may be prevented by hearing conservation programs and workplace health and safety trainings. Currently, we have limited knowledge on the potential associations between NIHL and hypercholesterolemia. Controlled human studies are limited, and a comprehensive study design is not feasible due to ethical issues. We will effectively assess this potential association in the future, provided that further advances in microcirculation imaging technologies are made, and that these technologies become available for clinical use.
